Chronic Hepatitis B and C Recall Northern Holland
The project aims to retrieve patients diagnosed with chronic hepatitis B (cHB) and hepatitis C (cHC) who are lost to follow-up.Data files of the Public Health System and microbiology laboratories will be explored for registered cases of cHB and cHC. Subsequently the investigators will compare the registered cases with the list of known cHB and cHC patients in hospital care. Patients lost to follow up will be informed and approached via either the Public Health Service (PHS) or their primary care physician. Identified patients will be invited for re-evaluation at the regional hepatitis centre (The North Western Hospital, formerly Medical Centre Alkmaar) to assess the current status of their chronic disease. Evaluation will be performed in accordance with (inter-)national guidelines, no extra interventions will be performed.
After completion of re-evaluation, a final report will be made and send to both patient and primary care physician with recommendations for further follow-up.
|Study Type:||Observational [Patient Registry]|
|Study Design:||Observational Model: Cohort|
|Target Follow-Up Duration:||1 Year|
|Official Title:||Retrieval of Patients Chronically Infected With Hepatitis B or Hepatitis C in Northern Holland|
- Liver-related morbidity [ Time Frame: Baseline ] [ Designated as safety issue: No ]At baseline, development of liver related morbidity due to chronic viral hepatitis will be assessed.
|Study Start Date:||February 2016|
|Estimated Study Completion Date:||December 2016|
|Estimated Primary Completion Date:||September 2016 (Final data collection date for primary outcome measure)|
Chronic hepatitis B
Patients diagnosed with chronic hepatitis B
Chronic hepatitis C
Patients diagnosed with chronic hepatitis C
Please refer to this study by its ClinicalTrials.gov identifier: NCT02687061
|Contact: Nina Beekmans, MD||+31725484444 ext firstname.lastname@example.org|
|Contact: Michael Klemt-Kropp, MD, PhD||+3172548444 ext 5058||M.Klemt-Kropp@nwz.nl|
|Principal Investigator:||Michael Klemt-Kropp, MD, PhD||Stichting MDL Holland-Noord|